TY  - JOUR
AU  - Incze, András
AU  - Kaló, Zoltán
AU  - Espín, Jaime
AU  - Kiss, Éva
AU  - Kessabi, Sophia
AU  - Garrison, Louis P
PY  - 2022
DO  - 10.3389/fphar.2022.815029
SN  - 1663-9812
UR  - http://hdl.handle.net/10668/20702
T2  - Frontiers in pharmacology
AB  - Background: External reference pricing (ERP) is used to set pharmaceutical prices to improve affordability, but its application may have negative consequences on patient access-thus, equity-across countries and on global innovation. With the United...
LA  - en
KW  - External Reference Pricing
KW  - Patient Access
KW  - Pharmaceutical Innovation
KW  - Price Regulation
KW  - U.S.
KW  - Worldwide
TI  - Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications.
TY  - research article
VL  - 13
ER  -